From the Muscular Dystrophy Association Insights in Research Investor Summit
Moderator:
- Michael Rice, MS, MBA, SVP, BioConsulting, Head of Advanced Therapeutics and Rare Diseases, Lumanity
Panelists:
- Chris Garabedian, Xontogeny and Portfolio Manager, PXV Fund
- Beth Seidenberg, Westlake Village BioPartners
- Sharon Hesterlee, PhD, Muscular Dystrophy Association (MDA)
- Lea Hachigian, Longwood Fund
- Inbal Michailovici, FutureRx
